-
1
-
-
0027239723
-
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment
-
PMID: 8336186
-
Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11:1466-77; PMID: 8336186
-
(1993)
J Clin Oncol
, vol.11
, pp. 1466-1477
-
-
Brodeur, G.M.1
Pritchard, J.2
Berthold, F.3
Carlsen, N.L.4
Castel, V.5
Castelberry, R.P.6
De Bernardi, B.7
Evans, A.E.8
Favrot, M.9
Hedborg, F.10
-
2
-
-
63249090501
-
New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence
-
PMID:19318043
-
Schor NF. New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence. Pharmacol Ther 2009; 122:44-55; PMID:19318043
-
(2009)
Pharmacol Ther
, vol.122
, pp. 44-55
-
-
Schor, N.F.1
-
3
-
-
0037366067
-
Neuroblastoma: Biological insights into a clinical enigma
-
PMID:12612655
-
Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003; 3:203-16; PMID:12612655
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 203-216
-
-
Brodeur, G.M.1
-
4
-
-
0035170157
-
Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: A report from the European Neuroblastoma Study Group "Survey"
-
PMID:11464893
-
Cotterill SJ, Pearson AD, Pritchard J, Kohler JA, Foot AB, European Neuroblastoma Study G, United Kingdom Children's Cancer Study G. Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: a report from the European Neuroblastoma Study Group "Survey". Med Pediatr Oncol 2001; 36:235-8; PMID:11464893
-
(2001)
Med Pediatr Oncol
, vol.36
, pp. 235-238
-
-
Cotterill, S.J.1
Pearson, A.D.2
Pritchard, J.3
Kohler, J.A.4
Foot, A.B.5
-
5
-
-
77953523121
-
Recent advances in neuroblastoma
-
PMID:20558371
-
Maris JM. Recent advances in neuroblastoma. N Engl J Med 2010; 362:2202-11; PMID:20558371
-
(2010)
N Engl J Med
, vol.362
, pp. 2202-2211
-
-
Maris, J.M.1
-
6
-
-
0029030908
-
Hemorrhagic intracranial parenchymal metastases from primary retroperitoneal neuroblastoma
-
PMID:7567239
-
Aronson MR, Smoker WR, Oetting GM. Hemorrhagic intracranial parenchymal metastases from primary retroperitoneal neuroblastoma. Pediatr Radiol 1995; 25:284-5; PMID:7567239
-
(1995)
Pediatr Radiol
, vol.25
, pp. 284-285
-
-
Aronson, M.R.1
Smoker, W.R.2
Oetting, G.M.3
-
7
-
-
33846051928
-
Mechanisms of invasion and metastasis in human neuroblastoma
-
PMID:17160711
-
Ara T, DeClerck YA. Mechanisms of invasion and metastasis in human neuroblastoma. Cancer Metastasis Rev 2006; 25:645-57; PMID:17160711
-
(2006)
Cancer Metastasis Rev
, vol.25
, pp. 645-657
-
-
Ara, T.1
DeClerck Y.A2
-
9
-
-
84876950650
-
Targeting tumor cell motility as a strategy against invasion and metastasis
-
PMID:23571046
-
Wells A, Grahovac J, Wheeler S, Ma B, Lauffenburger D. Targeting tumor cell motility as a strategy against invasion and metastasis. Trends Pharmacol Sci 2013; 34:283-9; PMID:23571046
-
(2013)
Trends Pharmacol Sci
, vol.34
, pp. 283-289
-
-
Wells, A.1
Grahovac, J.2
Wheeler, S.3
Ma, B.4
Lauffenburger, D.5
-
10
-
-
0030567914
-
Cell motility. Making connections count
-
PMID: 8837766
-
Lauffenburger DA. Cell motility. Making connections count. Nature 1996; 383:390-1; PMID: 8837766
-
(1996)
Nature
, vol.383
, pp. 390-391
-
-
Lauffenburger, D.A.1
-
11
-
-
0030045346
-
Cell migration: A physically integrated molecular process
-
PMID:8608589
-
Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996; 84:359-69; PMID:8608589
-
(1996)
Cell
, vol.84
, pp. 359-369
-
-
Lauffenburger, D.A.1
Horwitz, A.F.2
-
12
-
-
0037161744
-
HDAC6 is a microtubule-associated deacetylase
-
PMID:12024216
-
Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, Yoshida M, Wang XF, Yao TP. HDAC6 is a microtubule-associated deacetylase. Nature 2002; 417:455-8; PMID:12024216
-
(2002)
Nature
, vol.417
, pp. 455-458
-
-
Hubbert, C.1
Guardiola, A.2
Shao, R.3
Kawaguchi, Y.4
Ito, A.5
Nixon, A.6
Yoshida, M.7
Wang, X.F.8
Yao, T.P.9
-
13
-
-
34447315270
-
HDAC6 modulates cell motility by altering the acetylation level of cortactin
-
PMID:17643370
-
Zhang X, Yuan Z, Zhang Y, Yong S, Salas-Burgos A, Koomen J, Olashaw N, Parsons JT, Yang XJ, Dent SR, et al. HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol Cell 2007; 27:197-213; PMID:17643370
-
(2007)
Mol Cell
, vol.27
, pp. 197-213
-
-
Zhang, X.1
Yuan, Z.2
Zhang, Y.3
Yong, S.4
Salas-Burgos, A.5
Koomen, J.6
Olashaw, N.7
Parsons, J.T.8
Yang, X.J.9
Dent, S.R.10
-
14
-
-
27144475816
-
Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors
-
PMID:16121216
-
Bradbury CA, Khanim FL, Hayden R, Bunce CM, White DA, Drayson MT, Craddock C, Turner BM. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia 2005; 19:1751-9; PMID:16121216
-
(2005)
Leukemia
, vol.19
, pp. 1751-1759
-
-
Bradbury, C.A.1
Khanim, F.L.2
Hayden, R.3
Bunce, C.M.4
White, D.A.5
Drayson, M.T.6
Craddock, C.7
Turner, B.M.8
-
15
-
-
34547882857
-
Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma
-
PMID:16773191
-
Sakuma T, Uzawa K, Onda T, Shiiba M, Yokoe H, Shibahara T, Tanzawa H. Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma. Int J Oncol 2006; 29:117-24; PMID:16773191
-
(2006)
Int J Oncol
, vol.29
, pp. 117-124
-
-
Sakuma, T.1
Uzawa, K.2
Onda, T.3
Shiiba, M.4
Yokoe, H.5
Shibahara, T.6
Tanzawa, H.7
-
16
-
-
58149330694
-
Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor
-
PMID:19010849
-
Bazzaro M, Lin Z, Santillan A, Lee MK, Wang MC, Chan KC, Bristow RE, Mazitschek R, Bradner J, Roden RB. Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor. Clin Cancer Res 2008; 14:7340-7; PMID:19010849; http://dx.doi.org/10.1158/1078-0432.CCR-08-0642
-
(2008)
Clin Cancer Res
, vol.14
, pp. 7340-7347
-
-
Bazzaro, M.1
Lin, Z.2
Santillan, A.3
Lee, M.K.4
Wang, M.C.5
Chan, K.C.6
Bristow, R.E.7
Mazitschek, R.8
Bradner, J.9
Roden, R.B.10
-
17
-
-
84918592736
-
Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells
-
Li D, Sun X, Zhang L, Yan B, Xie S, Liu R, Liu M, Zhou J. Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells. Protein Cell 2013.
-
(2013)
Protein Cell
-
-
Li, D.1
Sun, X.2
Zhang, L.3
Yan, B.4
Xie, S.5
Liu, R.6
Liu, M.7
Zhou, J.8
-
18
-
-
27144488205
-
Tetrazolium dyes as tools in cell biology: New insights into their cellular reduction
-
PMID:16216776
-
Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 2005; 11:127-52; PMID:16216776; http://dx.doi.org/10.1016/S1387-2656(05)11004-7
-
(2005)
Biotechnol Annu Rev
, vol.11
, pp. 127-152
-
-
Berridge, M.V.1
Herst, P.M.2
Tan, A.S.3
-
19
-
-
34347230544
-
Sulforhodamine B colorimetric assay for cytotoxicity screening
-
PMID:17406391
-
Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 2006; 1:1112-6; PMID:17406391; http://dx.doi.org/10.1038/nprot.2006.179
-
(2006)
Nat Protoc
, vol.1
, pp. 1112-1116
-
-
Vichai, V.1
Kirtikara, K.2
-
20
-
-
0031455371
-
Regulation of cell migration by the calcium-dependent protease calpain
-
PMID:9407041
-
Huttenlocher A, Palecek SP, Lu Q, Zhang W, Mellgren RL, Lauffenburger DA, Ginsberg MH, Horwitz AF. Regulation of cell migration by the calcium-dependent protease calpain. J Biol Chem 1997; 272:32719-22; PMID:9407041; http://dx.doi.org/10.1074/jbc.272.52.32719
-
(1997)
J Biol Chem
, vol.272
, pp. 32719-32722
-
-
Huttenlocher, A.1
Palecek, S.P.2
Lu, Q.3
Zhang, W.4
Mellgren, R.L.5
Lauffenburger, D.A.6
Ginsberg, M.H.7
Horwitz, A.F.8
-
21
-
-
0034659405
-
Active maintenance of mHDA2/mHDAC6 histone-deacetylase in the cytoplasm
-
PMID:10873806
-
Verdel A, Curtet S, Brocard MP, Rousseaux S, Lemercier C, Yoshida M, Khochbin S. Active maintenance of mHDA2/mHDAC6 histone-deacetylase in the cytoplasm. Curr Biol 2000; 10:747-9; PMID:10873806; http://dx.doi.org/10.1016/S0960-9822(00)00542-X
-
(2000)
Curr Biol
, vol.10
, pp. 747-749
-
-
Verdel, A.1
Curtet, S.2
Brocard, M.P.3
Rousseaux, S.4
Lemercier, C.5
Yoshida, M.6
Khochbin, S.7
-
22
-
-
78650742637
-
The role of HDAC6 in cancer
-
PMID:21076528
-
Aldana-Masangkay GI, Sakamoto KM. The role of HDAC6 in cancer. J Biomed Biotechnol 2011; 2011:875824; PMID:21076528; http://dx.doi.org/10.1155/2011/875824
-
(2011)
J Biomed Biotechnol
, vol.2011
, pp. 875824
-
-
Aldana-Masangkay, G.I.1
Sakamoto, K.M.2
-
23
-
-
22744446856
-
Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer
-
PMID:15806142
-
Saji S, Kawakami M, Hayashi S, Yoshida N, Hirose M, Horiguchi S, Itoh A, Funata N, Schreiber SL, Yoshida M, et al. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer. Oncogene 2005; 24:4531-9; PMID:15806142; http://dx.doi.org/10.1038/sj.onc.1208646
-
(2005)
Oncogene
, vol.24
, pp. 4531-4539
-
-
Saji, S.1
Kawakami, M.2
Hayashi, S.3
Yoshida, N.4
Hirose, M.5
Horiguchi, S.6
Itoh, A.7
Funata, N.8
Schreiber, S.L.9
Yoshida, M.10
-
24
-
-
34248213405
-
HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions
-
PMID:17389687
-
Tran AD, Marmo TP, Salam AA, Che S, Finkelstein E, Kabarriti R, Xenias HS, Mazitschek R, Hubbert C, Kawaguchi Y, et al. HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions. J Cell Sci 2007; 120:1469-79; PMID:17389687; http://dx.doi.org/10.1242/jcs.03431
-
(2007)
J Cell Sci
, vol.120
, pp. 1469-1479
-
-
Tran, A.D.1
Marmo, T.P.2
Salam, A.A.3
Che, S.4
Finkelstein, E.5
Kabarriti, R.6
Xenias, H.S.7
Mazitschek, R.8
Hubbert, C.9
Kawaguchi, Y.10
-
25
-
-
0033646839
-
Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro
-
PMID:11107121
-
Coffey DC, Kutko MC, Glick RD, Swendeman SL, Butler L, Rifkind RA, Marks PA, Richon VM, La Quaglia MP. Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro. Med Pediatr Oncol 2000; 35:577-81; PMID:11107121; http://dx.doi.org/10.1002/1096-911X(20001201)35:6
-
(2000)
Med Pediatr Oncol
, vol.35
, pp. 577-581
-
-
Coffey, D.C.1
Kutko, M.C.2
Glick, R.D.3
Swendeman, S.L.4
Butler, L.5
Rifkind, R.A.6
Marks, P.A.7
Richon, V.M.8
La Quaglia, M.P.9
-
26
-
-
0035328528
-
The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with alltrans retinoic acid
-
PMID:11325825
-
Coffey DC, Kutko MC, Glick RD, Butler LM, Heller G, Rifkind RA, Marks PA, Richon VM, La Quaglia MP. The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with alltrans retinoic acid. Cancer Res 2001; 61:3591-4; PMID:11325825
-
(2001)
Cancer Res
, vol.61
, pp. 3591-3594
-
-
Coffey, D.C.1
Kutko, M.C.2
Glick, R.D.3
Butler, L.M.4
Heller, G.5
Rifkind, R.A.6
Marks, P.A.7
Richon, V.M.8
La Quaglia, M.P.9
-
27
-
-
4444343940
-
Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma
-
PMID:15355914
-
Tang XX, Robinson ME, Riceberg JS, Kim DY, Kung B, Titus TB, Hayashi S, Flake AW, Carpentieri D, Ikegaki N. Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma. Clin Cancer Res 2004; 10:5837-44; PMID:15355914; http://dx.doi.org/10.1158/1078-0432.CCR-04-0395
-
(2004)
Clin Cancer Res
, vol.10
, pp. 5837-5844
-
-
Tang, X.X.1
Robinson, M.E.2
Riceberg, J.S.3
Kim, D.Y.4
Kung, B.5
Titus, T.B.6
Hayashi, S.7
Flake, A.W.8
Carpentieri, D.9
Ikegaki, N.10
-
28
-
-
14244258090
-
Histone deacetylase inhibitor BL1521 induces a G1-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins
-
PMID:15733867
-
Ouwehand K, de Ruijter AJ, van Bree C, Caron HN, van Kuilenburg AB. Histone deacetylase inhibitor BL1521 induces a G1-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins. FEBS Lett 2005; 579:1523-8; PMID:15733867; http://dx.doi.org/10.1016/j.febslet.2005.01.058
-
(2005)
FEBS Lett
, vol.579
, pp. 1523-1528
-
-
Ouwehand, K.1
De Ruijter, A.J.2
Van Bree, C.3
Caron, H.N.4
Van Kuilenburg, A.B.5
-
29
-
-
16344376556
-
Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors
-
PMID:15778293
-
Subramanian C, Opipari AW, Jr., Bian X, Castle VP, Kwok RP. Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci U S A 2005; 102:4842-7; PMID:15778293; http://dx.doi.org/10.1073/pnas.0408351102
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 4842-4847
-
-
Subramanian, C.1
Opipari, A.W.2
Bian, X.3
Castle, V.P.4
Kwok, R.P.5
-
30
-
-
34250822248
-
CREB-binding protein is a mediator of neuroblastoma cell death induced by the histone deacetylase inhibitor trichostatin A
-
PMID:17603632
-
Subramanian C, Jarzembowski JA, Opipari AW, Jr., Castle VP, Kwok RP. CREB-binding protein is a mediator of neuroblastoma cell death induced by the histone deacetylase inhibitor trichostatin A. Neoplasia 2007; 9:495-503; PMID:17603632; http://dx.doi.org/10.1593/neo.07262
-
(2007)
Neoplasia
, vol.9
, pp. 495-503
-
-
Subramanian, C.1
Jarzembowski, J.A.2
Opipari, A.W.3
Castle, V.P.4
Kwok, R.P.5
-
31
-
-
47349097996
-
Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells
-
PMID: 18549473
-
Muhlethaler-Mottet A, Meier R, Flahaut M, Bourloud KB, Nardou K, Joseph JM, Gross N. Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells. Mol Cancer 2008; 7:55; PMID: 18549473
-
(2008)
Mol Cancer
, vol.7
, pp. 55
-
-
Muhlethaler-Mottet, A.1
Meier, R.2
Flahaut, M.3
Bourloud, K.B.4
Nardou, K.5
Joseph, J.M.6
Gross, N.7
-
32
-
-
84857140530
-
Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells
-
PMID:22186300
-
Francisco R, Perez-Perarnau A, Cortes C, Gil J, Tauler A, Ambrosio S. Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells. Cancer Lett 2012; 318:42-52; PMID:22186300
-
(2012)
Cancer Lett
, vol.318
, pp. 42-52
-
-
Francisco, R.1
Perez-Perarnau, A.2
Cortes, C.3
Gil, J.4
Tauler, A.5
Ambrosio, S.6
-
33
-
-
84882667367
-
RuvBL2 is involved in histone deacetylase inhibitor PCI-24781-induced cell death in SK-N-DZ neuroblastoma cells
-
PMID:23977108
-
Zhan Q, Tsai S, Lu Y, Wang C, Kwan Y, Ngai S. RuvBL2 is involved in histone deacetylase inhibitor PCI-24781-induced cell death in SK-N-DZ neuroblastoma cells. PLoS One 2013; 8:e71663; PMID:23977108
-
(2013)
PLoS One
, vol.8
, pp. e71663
-
-
Zhan, Q.1
Tsai, S.2
Lu, Y.3
Wang, C.4
Kwan, Y.5
Ngai, S.6
-
34
-
-
80051496447
-
HDAC6 deacetylates Ku70 and regulates Ku70-Bax binding in neuroblastoma
-
PMID:21847364
-
Subramanian C, Jarzembowski JA, Opipari AW, Jr., Castle VP, Kwok RP. HDAC6 deacetylates Ku70 and regulates Ku70-Bax binding in neuroblastoma. Neoplasia 2011; 13:726-34; PMID:21847364
-
(2011)
Neoplasia
, vol.13
, pp. 726-734
-
-
Subramanian, C.1
Jarzembowski, J.A.2
Opipari, A.W.3
Castle, V.P.4
Kwok, R.P.5
-
35
-
-
0344640906
-
Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation
-
PMID:12677000
-
Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci U S A 2003; 100:4389-94; PMID:12677000
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 4389-4394
-
-
Haggarty, S.J.1
Koeller, K.M.2
Wong, J.C.3
Grozinger, C.M.4
Schreiber, S.L.5
-
36
-
-
30344477367
-
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
-
PMID:16397526
-
Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 2006; 6:38-51; PMID:16397526
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 38-51
-
-
Minucci, S.1
Pelicci, P.G.2
-
37
-
-
33845514708
-
Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds?
-
PMID:17109024
-
Karagiannis TC, El-Osta A. Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds? Leukemia 2007; 21:61-5; PMID:17109024
-
(2007)
Leukemia
, vol.21
, pp. 61-65
-
-
Karagiannis, T.C.1
El-Osta, A.2
-
38
-
-
20844435806
-
Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma
-
PMID:15937109
-
Hideshima T, Bradner JE, Wong J, Chauhan D, Richardson P, Schreiber SL, Anderson KC. Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma. Proc Natl Acad Sci U S A 2005; 102:8567-72; PMID:15937109
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 8567-8572
-
-
Hideshima, T.1
Bradner, J.E.2
Wong, J.3
Chauhan, D.4
Richardson, P.5
Schreiber, S.L.6
Anderson, K.C.7
-
39
-
-
51049100212
-
Requirement of HDAC6 for transforming growth factor-beta(1)-induced epithelial-mesenchymal transition
-
PMID:18499657
-
Shan B, Yao TP, Nguyen HT, Zhuo Y, Levy DR, Klingsberg RC, Tao H, Palmer ML, Holder KN, Lasky JA. Requirement of HDAC6 for transforming growth factor-beta(1)-induced epithelial-mesenchymal transition. J Biol Chem 2008; 283:21065-73; PMID:18499657
-
(2008)
J Biol Chem
, vol.283
, pp. 21065-21073
-
-
Shan, B.1
Yao, T.P.2
Nguyen, H.T.3
Zhuo, Y.4
Levy, D.R.5
Klingsberg, R.C.6
Tao, H.7
Palmer, M.L.8
Holder, K.N.9
Lasky, J.A.10
-
40
-
-
67650541859
-
Tubacin kills Epstein-Barr virus (EBV)-Burkitt lymphoma cells by inducing reactive oxygen species and EBV lymphoblastoid cells by inducing apoptosis
-
PMID:19386607
-
Kawada J, Zou P, Mazitschek R, Bradner JE, Cohen JI. Tubacin kills Epstein-Barr virus (EBV)-Burkitt lymphoma cells by inducing reactive oxygen species and EBV lymphoblastoid cells by inducing apoptosis. J Biol Chem 2009; 284:17102-9; PMID:19386607
-
(2009)
J Biol Chem
, vol.284
, pp. 17102-17109
-
-
Kawada, J.1
Zou, P.2
Mazitschek, R.3
Bradner, J.E.4
Cohen, J.I.5
|